Respicardia

Health healthtech medical devices therapy

Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time.

Total Funding

$149.1 M

Type

Private

Hopkins, US

Founded

2006

Size (employees)

24 (est)+10%

Website

respicardia.com

Respicardia was founded in 2006 and is headquartered in Hopkins, US

Report incorrect company information

Key People/Management at Respicardia

Bonnie Labosky

President and CEO

Tim Hauch

CFO

Robin Germany

Chief Medical Officer

Todd Goblish

Vice President of Research and Development

Report incorrect company information

Respicardia Office Locations

Respicardia has an office in Hopkins

Hopkins, US (HQ)

150 12400 Whitewater Dr

Show all (1)

Report incorrect company information

Respicardia Financials and Metrics

Summary Metrics

Founding Date	2006
Total Funding	$149.1 m
Latest funding size	$58.50 m
Time since last funding	6 months ago
Investors	Sorin Group, Polaris Venture Capital, Three Arch Partners, RK Ventures Group, Polaris Partners, Accuitive Medical Ventures, ZOLL Medical Corporation, Abbott, Versant Ventures, Affinity Capital Management